US Stock MarketDetailed Quotes

MAYNF MAYNE PHARMA GROUP LIMITED

Watchlist
  • 4.470000
  • 0.0000000.00%
15min DelayClose Apr 4 16:00 ET
380.28MMarket Cap-2329P/E (TTM)

About MAYNE PHARMA GROUP LIMITED Company

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Company Profile

SymbolMAYNF
Company NameMAYNE PHARMA GROUP LIMITED
Founded2005
CEOMr. Shawn Patrick O’Brien
MarketPink Market
Employees1000
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address1538 Main North Road,Salisbury South
CitySalisbury
ProvinceSouth Australia (SA)
CountryAustralia
Zip Code5106
Phone61-8-8209-2666

Company Executives

  • Name
  • Position
  • Salary
  • Shawn Patrick O’Brien
  • Director, Managing Director and Chief Executive Officer
  • --
  • Frank Charles Condella, M.B.A.
  • Chairman of the Board
  • --
  • David Petrie
  • Director
  • --
  • Professor Bruce Robinson, A.C.,F.R.A.C.P.,M.D.
  • Independent Director
  • --
  • Ann Custin, C.P.A.
  • Independent Director
  • --
  • Patrick J. Blake
  • Independent Director
  • --
  • Dr. Kathryn MacFarlane, Pharm.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg